Underuse of oral anticoagulants in atrial fibrillation: a systematic review.

By I. Ogilvie, N. Newton, S. Welner, W. Cowell, Gregory Y. H. Lip. American Journal of Medicine, 2010

954 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Neurology

View Paper: https://www.semanticscholar.org/paper/1ae190a40aee082a89a0a456c69211e8ac3a2b86

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. J. Halperin
2. Robert M. Califf

In Neurology

1. Richard C. Becker

Citations in the corpus

• Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. (2011, background): “Irrespective of geographic location, observational studies reveal that older patients with AF and those with renal dysfunction are undertreated with anticoagulants.(5,25,26) Concerns about bleeding and falls among frail patients with AF have often led to the decision not to treat with anticoagulants”